Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment

This treatment trial (n=40) aims to enhance depression relief among patients already undergoing esketamine treatment by introducing computer-based cognitive training.

The University of Pittsburgh is conducting the study to test whether this adjunctive intervention can improve depression outcomes. Participants aged 18 to 80 will be randomly assigned to receive either cognitive training or sham training over eight web-based sessions.

The primary outcome measures include depression severity, assessed by the Montgomery Asberg Depression Rating Scale, and self-reported depression symptoms, measured by the Quick Inventory of Depressive Symptoms.

Secondary outcomes include clinician-rated depression, clinical global impression scales, and measures of treatment satisfaction. The study started on February 14, 2023, and is estimated to complete by August 1, 2025.

Trial Details

In a sample of patients already receiving esketamine treatment as part of their clinical care, this project seeks to test whether we can improve depression by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat depression more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.

Trial Number NCT05719909

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.